Acadia Healthcare (ACHC) – Analysts’ Recent Ratings Changes

A number of firms have modified their ratings and price targets on shares of Acadia Healthcare (NASDAQ: ACHC) recently:

• 7/29/2026 – Acadia Healthcare had its “neutral” rating reaffirmed by Cantor Fitzgerald.
• 7/14/2026 – Acadia Healthcare had its price target raised by KeyCorp from $30.00 to $40.00. They now have an “overweight” rating on the stock.
• 7/14/2026 – Acadia Healthcare had its price target raised by TD Cowen from $30.00 to $36.00. They now have a “buy” rating on the stock.
• 7/9/2026 – Acadia Healthcare had its price target raised by UBS Group AG from $31.00 to $39.00. They now have a “buy” rating on the stock.
• 6/12/2026 – Acadia Healthcare had its “sell (d)” rating reaffirmed by Weiss Ratings.
• 6/3/2026 – Acadia Healthcare was upgraded by Jefferies Financial Group Inc. from “hold” to “buy”. They now have a $30.00 price target on the stock, up from $24.50.

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.